Targretin bexarotene capsules regulatory update

The FDA's Oncologic Drugs Advisory Committee (ODAC) voted 13-2, with one abstention, to recommend approval of LGND's Targretin small molecule retinoid X receptor ( RXR) specific ligand to treat advan...